Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency


Creative Commons License

Aydin S. E., Freeman A. F., Al-Herz W., Al-Mousa H. A., Arnaout R. K., Aydin R. C., ...Daha Fazla

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, cilt.7, sa.3, ss.848-855, 2019 (SCI-Expanded) identifier identifier identifier

Özet

BACKGROUND: Biallelic variations in the dedicator of cytokinesis 8 (DOCK8) gene cause a combined immunodeficiency with eczema, recurrent bacterial and viral infections, and malignancy. Natural disease outcome is dismal, but allogeneic hematopoietic stem cell transplantation (HSCT) can cure the disease.